PIQ Proteomics notches up as company launches PromarkerD into the US Proteomics (ASX:PIQ) has seen shares pop just over +4% in early Friday trades after launching its PromarkerD product into the... Jonathon Davidson 2 days ago ASX News Healthcare Biotechnology
RCE Recce locks in $30M to boost commercialisation across ASEAN region Recce Pharmaceuticals (ASX:RCE) has secured the first tranche of a $30M debt facility to continue running skin infection... Jonathon Davidson 5 days ago ASX News Healthcare Biotechnology
MEM Many are concerned about global falling birthrates. This diverse stock has solutions Outside of US politics, there is one issue that’s been popping up more and more across social media and other forums of commentary in 2025... Jonathon Davidson 5 days ago ASX News Healthcare Technology Scientific & Technical Instruments
NUZ This stock is crafting a cure for Huntington's – and it's making progress Neurizon Therapeutics (ASX:NUZ) has declared that its in-house product NUZ-001 Sulfone granted neuroprotective effects... Jonathon Davidson 6 days ago ASX News Healthcare Biotechnology
CUV Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't... Jonathon Davidson 13 Jun 2025 10:45 (AEST) ASX News Healthcare Biotechnology
FRE Study spruiks Firebrick's Nasodine spray as 'effective treatment for common cold' A long-run study looking into leading Firebrick Pharma (ASX:FRE) product Nasodine has suggested the nasal spray can be an effective treatment for the common cold following a dive into the company’s Phase III trials.Listen to the HotCopper podcast for in-depth discussions and insig... Isaac McIntyre 10 Jun 2025 10:07 (AEST) ASX News Healthcare Biotechnology
PIQ Proteomics claims it can diagnose throat cancer with blood test Proteomics International (ASX:PIQ) has popped +6% after reporting the "high accuracy" of its blood test for throat cancer. Jonathon Davidson 05 Jun 2025 13:24 (AEST) ASX News Healthcare Biotechnology
RCE 'Critical step': Go for Recce's Phase III trials after banking $15.8M in capital raise Recce Pharmaceuticals (ASX:RCE) has successfully filled its coffers ahead of its Phase III clinical trials in Indonesia and Australia, with the company this week landing @firm commitments” to place the full shortfall in its capital raise.Listen to the HotCopper podcast for i... Isaac McIntyre 04 Jun 2025 09:29 (AEST) ASX News Healthcare Biotechnology
PAR Paradigm activates first Aus site for osteoarthritis drug trials Paradigm Biopharmaceuticals Ltd has opened its first Australian site as part of a trial to assess injectable pentosan polysulfate sodium Caroline Smith 03 Jun 2025 12:08 (AEST) ASX News Healthcare Biotechnology
CDX Cardiex wins TGA greenlight; shares jump +11% Cardiex Ltd (ASX:CDX) has popped +11% intraday to 4.7cps as the smallcap healthcare stock wins a key approval from the TGA. Jonathon Davidson 02 Jun 2025 11:47 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
DXB Dimerix launches key trial in Japan as recruitment kicks off Dimerix (ASX:DXB) has kicked off a key trial in Japan (in terms of patient recruitment) seeking to treat inflammatory diseases. Jonathon Davidson 30 May 2025 11:08 (AEST) ASX News Healthcare Biotechnology
BP8 BP8 ships first Indonesian seaweed under cornerstone partnership BP8 Global Ltd has made its first shipment of Indonesian seaweed to a South Korean food ingredient manufacturer Caroline Smith 29 May 2025 14:09 (AEST) ASX News Agriculture Consumer Cyclical Healthcare Biotechnology
RNV ReNerve snaffles approval in Bahrain, looks to expand throughout the ME ReNerve Ltd has received marketing approval from Bahrain which will see its nerve repair devices commercialised throughout the country Caroline Smith 28 May 2025 13:21 (AEST) ASX News Healthcare Steel Medical Devices Basic Materials
